抗肥胖药物在 2 型糖尿病管理中的应用：思维的转变？

Antiobesity drugs in the management of type 2 diabetes: A shift in thinking?

机构信息

Director of Obesity Programs, Endocrinology & Metabolism Institute, Cleveland Clinic, Cleveland, OH, USA.

Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.

出版信息

Cleve Clin J Med. 2017 Jul;84(7 Suppl 1):S39-S46. doi: 10.3949/ccjm.84.s1.05.

DOI:10.3949/ccjm.84.s1.05

PMID:28708481

Abstract

Antiobesity medications can improve metabolic control for patients with type 2 diabetes mellitus (DM) and obesity, but are underutilized. In this review, we describe the role of antiobesity drugs in the context of medically supervised and comprehensive weight-loss interventions and propose a pragmatic therapeutic algorithm for patients with type 2 DM and obesity that incorporates the use of antiobesity drugs early in the course of management.

摘要

减肥药可改善 2 型糖尿病（DM）和肥胖症患者的代谢控制，但使用率较低。在本综述中，我们将描述减肥药在医学监督和综合减重干预措施背景下的作用，并为 2 型 DM 和肥胖症患者提出一个实用的治疗算法，该算法在管理过程中早期就包含使用减肥药。